Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fast

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Chemmedchem|February 28, 2014
Developing an irreversible inhibitor of human DDAH-1, an enzyme upregulated in melanomaYun Wang, Shougang Hu, Abdul M Gabisi, et al.
Chemical Science|June 14, 2021
Elusive structural changes of New Delhi metallo-β-lactamase revealed by ultraviolet photodissociation mass spectrometryM Rachel Mehaffey, Yeong-Chan Ahn, Dann D Rivera, et al.
Archives of Biochemistry and Biophysics|April 9, 2026
Discovery and Characterization of a Covalent Inhibitor of New Delhi Metallo β-LactamaseDann D Rivera, John M Schroeder, Jada N Walker, et al.
ACS Infectious Diseases|July 24, 2025
Inhibitor Affinity Differs among Clinical Variants of IMP Metallo-<b>β</b>-Lactamases: Analysis and Implications for Inhibitor DesignCaitlyn A Thomas, John Paul Alao, Thomas Smisek, et al.
Journal of the American Chemical Society|May 26, 2021
Visualizing the Dynamic Metalation State of New Delhi Metallo-β-lactamase-1 in Bacteria Using a Reversible Fluorescent ProbeRadhika Mehta, Dann D Rivera, David J Reilley, et al.
The Journal of Biological Chemistry|June 18, 2018
Evolution of New Delhi metallo-β-lactamase (NDM) in the clinic: Effects of NDM mutations on stability, zinc affinity, and mono-zinc activityZishuo Cheng, Pei W Thomas, Lincheng Ju, et al.
ACS Infectious Diseases|March 30, 2022
Discovery of an Effective Small-Molecule Allosteric Inhibitor of New Delhi Metallo-β-lactamase (NDM)Pei W Thomas, Eun Jeong Cho, Christopher R Bethel, et al.
ACS Infectious Diseases|October 3, 2017
Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc ScarcityAlesha C Stewart, Christopher R Bethel, Jamie VanPelt, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Carbapenem Use Is Driving the Evolution of Imipenemase 1 VariantsZishuo Cheng, Christopher R Bethel, Pei W Thomas, et al.
Biomolecules|March 20, 2020
MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo--Lactamase InhibitorsZishuo Cheng, Caitlyn A Thomas, Adam R Joyner, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Chemmedchem|February 28, 2014
Developing an irreversible inhibitor of human DDAH-1, an enzyme upregulated in melanomaYun Wang, Shougang Hu, Abdul M Gabisi, et al.
Chemical Science|June 14, 2021
Elusive structural changes of New Delhi metallo-β-lactamase revealed by ultraviolet photodissociation mass spectrometryM Rachel Mehaffey, Yeong-Chan Ahn, Dann D Rivera, et al.
Archives of Biochemistry and Biophysics|April 9, 2026
Discovery and Characterization of a Covalent Inhibitor of New Delhi Metallo β-LactamaseDann D Rivera, John M Schroeder, Jada N Walker, et al.
ACS Infectious Diseases|July 24, 2025
Inhibitor Affinity Differs among Clinical Variants of IMP Metallo-<b>β</b>-Lactamases: Analysis and Implications for Inhibitor DesignCaitlyn A Thomas, John Paul Alao, Thomas Smisek, et al.
Journal of the American Chemical Society|May 26, 2021
Visualizing the Dynamic Metalation State of New Delhi Metallo-β-lactamase-1 in Bacteria Using a Reversible Fluorescent ProbeRadhika Mehta, Dann D Rivera, David J Reilley, et al.
The Journal of Biological Chemistry|June 18, 2018
Evolution of New Delhi metallo-β-lactamase (NDM) in the clinic: Effects of NDM mutations on stability, zinc affinity, and mono-zinc activityZishuo Cheng, Pei W Thomas, Lincheng Ju, et al.
ACS Infectious Diseases|March 30, 2022
Discovery of an Effective Small-Molecule Allosteric Inhibitor of New Delhi Metallo-β-lactamase (NDM)Pei W Thomas, Eun Jeong Cho, Christopher R Bethel, et al.
ACS Infectious Diseases|October 3, 2017
Clinical Variants of New Delhi Metallo-β-Lactamase Are Evolving To Overcome Zinc ScarcityAlesha C Stewart, Christopher R Bethel, Jamie VanPelt, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Carbapenem Use Is Driving the Evolution of Imipenemase 1 VariantsZishuo Cheng, Christopher R Bethel, Pei W Thomas, et al.
Biomolecules|March 20, 2020
MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo--Lactamase InhibitorsZishuo Cheng, Caitlyn A Thomas, Adam R Joyner, et al.
Pageof 8